Literature DB >> 21987301

Infliximab-induced autoimmune hepatitis in Crohn's disease treated with budesonide and mycophenolate.

K Subramaniam, S Chitturi, M Brown, P Pavli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21987301     DOI： 10.1002/ibd.21880

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  13 in total

Review 1.  Autoimmune hepatitis: a review.

Authors:  Andrea A Gossard; Keith D Lindor
Journal:  J Gastroenterol       Date:  2012-04-17       Impact factor: 7.527

Review 2.  Autoimmune hepatitis induced by adalimumab with successful switch to abatacept.

Authors:  A Grasland; R Sterpu; S Boussoukaya; I Mahe
Journal:  Eur J Clin Pharmacol       Date:  2011-12-29       Impact factor: 2.953

3.  Hepatotoxicity of anti-TNF agents.

Authors:  Maurizio Bonacini; Marwan Ghabril; Herbert L Bonkovsky
Journal:  Dig Dis Sci       Date:  2014-03-21       Impact factor: 3.199

Review 4.  Infliximab-related hepatitis: a case study and literature review.

Authors:  Francisco Colina; Aída Molero; Begoña Casís; Pilar Martínez-Montiel
Journal:  Dig Dis Sci       Date:  2013-05-05       Impact factor: 3.199

Review 5.  Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease.

Authors:  Ersilia M DeFilippis; Sonal Kumar
Journal:  Dig Dis Sci       Date:  2015-05-22       Impact factor: 3.199

Review 6.  Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management.

Authors:  Roberta Elisa Rossi; Ioanna Parisi; Edward John Despott; Andrew Kenneth Burroughs; James O'Beirne; Dario Conte; Mark Ian Hamilton; Charles Daniel Murray
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

7.  Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis.

Authors:  Pinelopi Arvaniti; George Giannoulis; Stella Gabeta; Kalliopi Zachou; George K Koukoulis; George N Dalekos
Journal:  JHEP Rep       Date:  2020-05-29

Review 8.  Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases.

Authors:  Marwan Ghabril; Herbert L Bonkovsky; Clarissa Kum; Tim Davern; Paul H Hayashi; David E Kleiner; Jose Serrano; Jim Rochon; Robert J Fontana; Maurizio Bonacini
Journal:  Clin Gastroenterol Hepatol       Date:  2013-01-17       Impact factor: 11.382

9.  Treatment of autoimmune liver disease: current and future therapeutic options.

Authors:  Palak J Trivedi; Gideon M Hirschfield
Journal:  Ther Adv Chronic Dis       Date:  2013-05       Impact factor: 5.091

10.  Liver Injury Secondary to Anti-TNF-Alpha Therapy in Inflammatory Bowel Disease: A Case Series and Review of the Literature.

Authors:  Ravish Parekh; Nirmal Kaur
Journal:  Case Rep Gastrointest Med       Date:  2014-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.